ARCHIVES

Avastin-Zybrestat Combination Increases Progression-Free Survival in Phase II Trial

This article is from The Cancer Letter archive.

Vol. 37 No. 3 | March 28, 2014

Download PDF Visit The Full Archive

Related Articles

The Cancer Letter Marks 25th Anniversary

December 18, 1998

“Whatever Happened To…?” ACS Follows Up Five Years Later

August 26, 1977

In Brief: Stephen Schimpff Accepts New Position Of Executive Vice President Of Univ. Of Maryland Medical System

October 4, 1985

In Brief: David Feigal To Head FDA’s Antiviral Division; ODAC To Discuss Melphalan, Amifostine NDAs

January 17, 1992

NCI Intramural Programs: Clinical Trials Support System Need Attention, report Advises DCS

December 19, 1997

Two-Month Survival Benefit For Some NSCLC Patients

May 31, 2002